— Know what they know.
Not Investment Advice

RBII OTC

Rising Biosciences, Inc.
1W: +0.0% 1M: +900.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -98.3% 5Y: -99.9%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 58 · $4991 mcap · 442M float · 0.061% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
-$70K -18.4% ▼
Capital Expenditures
$3 +100.0% ▲
Free Cash Flow
-$70K +50.0% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$47K +7668.6% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020
— Operating Activities —
Net Income-$253K$50K
Depreciation & Amort.$34K$34K
Stock-Based Comp.$0$0
Change in Working Capital$160K-$94K
Other Non-Cash Items$0-$60K
Operating Cash Flow-$59K-$70K
— Investing Activities —
Capital Expenditures-$81K$0
Acquisitions (Net)-$35K-$6K
Investment Purchases$0$0
Investment Sales$0$0
Other Investing$0$0
Investing Cash Flow-$116K-$6K
— Financing Activities —
Net Debt Issuance$0$110K
Stock Repurchased$0$0
Dividends Paid$0$0
Other Financing$176K-$4K
Financing Cash Flow$176K$124K
Net Change in Cash$608$47K
Cash End of Period$763$48K
Free Cash Flow-$141K-$70K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms